As of 2026-03-20, the EV/EBITDA ratio of Precigen Inc (PGEN) is -5.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 1,253.25 mil USD. PGEN's TTM EBITDA according to its financial statements is -235.99 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 14.9x | 11.8x |
| Forward P/E multiples | 11.8x - 17.2x | 15.4x |
| Fair Price | (8.08) - (10.19) | (9.29) |
| Upside | -343.3% - -406.8% | -379.9% |
| Date | EV/EBITDA |
| 2026-03-19 | -5.31 |
| 2026-03-18 | -5.24 |
| 2026-03-17 | -5.64 |
| 2026-03-16 | -5.60 |
| 2026-03-13 | -5.60 |
| 2026-03-12 | -5.25 |
| 2026-03-11 | -5.46 |
| 2026-03-10 | -5.60 |
| 2026-03-09 | -5.60 |
| 2026-03-06 | -5.31 |
| 2026-03-05 | -5.39 |
| 2026-03-04 | -5.66 |
| 2026-03-03 | -5.39 |
| 2026-03-02 | -5.76 |
| 2026-02-27 | -6.02 |
| 2026-02-26 | -6.05 |
| 2026-02-25 | -6.09 |
| 2026-02-24 | -6.30 |
| 2026-02-23 | -6.45 |
| 2026-02-20 | -6.90 |
| 2026-02-19 | -7.09 |
| 2026-02-18 | -7.65 |
| 2026-02-17 | -8.14 |
| 2026-02-13 | -7.72 |
| 2026-02-12 | -7.44 |
| 2026-02-11 | -7.69 |
| 2026-02-10 | -7.32 |
| 2026-02-09 | -7.17 |
| 2026-02-06 | -6.76 |
| 2026-02-05 | -6.69 |
| 2026-02-04 | -7.17 |
| 2026-02-03 | -7.53 |
| 2026-02-02 | -7.57 |
| 2026-01-30 | -7.06 |
| 2026-01-29 | -7.12 |
| 2026-01-28 | -7.02 |
| 2026-01-27 | -7.42 |
| 2026-01-26 | -7.45 |
| 2026-01-23 | -7.47 |
| 2026-01-22 | -7.59 |
| 2026-01-21 | -7.02 |
| 2026-01-20 | -6.91 |
| 2026-01-16 | -6.94 |
| 2026-01-15 | -6.54 |
| 2026-01-14 | -6.94 |
| 2026-01-13 | -6.58 |
| 2026-01-12 | -6.53 |
| 2026-01-09 | -7.21 |
| 2026-01-08 | -7.24 |
| 2026-01-07 | -7.60 |